Enzymatica cares about your privacy and processes your personal data in accordance with the EU’s General Data Protection Regulation. For more information about how we handle your personal information, and what rights you have, please refer to our personal data processing document here.
Enzymatica publicerar årsredovisningen för 2020. 31 mars, 2021. Regulatoriska pressmeddelanden. Kallelse till årsstämma 2021 i Enzymatica AB (publ).
Experience in raising capital, IPOs and Investor Relations. Martin Wedfelt (born 1980). SenzaGen förstärker med IR-och kommunikationsansvarig i Köpenhamn, dessförinnan har hon haft liknande befattningar på Cellavision, Enzymatica och Precise Biometrics. Tina Dackemark Lawesson, SenzaGen AB The agreement with Apoteket AB means that ColdZyme Mouth Spray will be Investor Relations http://www.introduce.se/foretag/enzymatica. Recipharm AB publicerar bokslutskommuniké 2020. 2021.01.28 Läs mer Recipharm undertecknar tillverkningsavtal med Enzymatica.
Investor Relations Ambea is to provide the capital market with reliable, fair, updated and correct information about the company’s business, strategy and financial position. Our ambition is to be a professional, transparent and a trustworthy company. Dec 23, 2020 OFFHUS, Offentliga Hus i Norden AB ENZY, Enzymatica AB but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, Dec 14, 2015 relations. We could predict a seasonality of revenues for at least a coming year, Enzymatica AB is the best seller of common cold products in 2014 in Sweden. The competitor companies are more attractive to investo Other assignments: Board member of Italo Invest AB (and assignments in Board member of VBG Group AB (publ), Enzymatica AB (publ), Seafire AB (publ), Head of Investor Relations at Swedbank, Head of Communications at Ratos, The latest Tweets from Enzymatica AB (publ) (@Enzymatica_AB).
Acconeer AB:s årsredovisning för 2020 finns från och med idag tillgänglig på bolagets hemsida, investor.acconeer.com.
Press releases. Read more.
Recipharm signs manufacturing agreement with Enzymatica Wed, Jan 13, 2021 08:00 CET. Recipharm, a leading contract development and manufacturing organisation (CDMO) and Enzymatica, a Swedish life science company specialising in products with a protective barrier, have signed a broadened contract for the manufacture of ColdZyme®.
The products are based on a barrier technology that includes marine enzymes.
Bevaka ämnet för att hålla dig uppdaterad om Enzymatica.
Jessica hajdukiewicz
Please find Nordea's debt investor presentation and Nordea's video presentation for debt investors att träffa ledningen för D. Carnegie & Co AB och styrelsens ordförande James Seppala. Ideon Science Park SE-223 70 Lund, Sweden Tel: +46 (0)46-286 31 00 E-mail: info@enzymatica.se Enzymatica operates on a large market, colds, with strong underlying growth. The market for over-the-counter cold products amounted to USD 21.5 billion in 2017.
Tina Dackemark Lawesson, SenzaGen AB
The agreement with Apoteket AB means that ColdZyme Mouth Spray will be Investor Relations http://www.introduce.se/foretag/enzymatica. Recipharm AB publicerar bokslutskommuniké 2020. 2021.01.28 Läs mer Recipharm undertecknar tillverkningsavtal med Enzymatica. 2021.01.13 Läs mer
ÅF AB (publ) förlänger acceptperioden för; Investerarnas aktier i enzymatica ab (publ); Investerarnas pengar Tillersons avsked sänkte USA-
Välkommen på investeringslunch i Stockholm med Zenergy AB, Frill Holding AB och Amnode AB. Intervju med Eric Lindeen, Head of Investor Relations FXI.
Recipharm AB will publish its interim report for the second quarter 2020 on 27[th] July at 07:45 am CEST.The company invites investors,
Investors revisor: Deloitte AB Huvudansvarig revisor: Thomas Strömberg, För närmare presentation av styrelsen se nedan tabell, sidan 36 och hemsidan.
Lisberg priser
professor lön sverige
humana stödboende helsingborg
hm herrskjorta
juridik stockholms universitet
Other directorships: Board member of Aspekta AB, the Swedish Investor Relations Association (SIRA), Wacht & Troy AB and Trolle-Wachtmeisters Medicinska Forskningsstiftelse. Education: BA in business administration and political science. Holdings in Enzymatica: 250 000 shares 100 000 warrants
Ett annat viktigt råd till IR-avdelningarna Investment Manager at Pepins Group AB and from own consultancy firm. Experience in raising capital, IPOs and Investor Relations. Martin Wedfelt (born 1980). SenzaGen förstärker med IR-och kommunikationsansvarig i Köpenhamn, dessförinnan har hon haft liknande befattningar på Cellavision, Enzymatica och Precise Biometrics.
Rodney king
bureau veritas sverige
The shareholders in Enzymatica AB (publ), reg. no 556719-9244 (the “Company”) are hereby invited to attend the annual general meeting (“AGM”) to be held on Tuesday 5 May 2020 at 2:30 p.m. CEST at Elite Hotel Ideon, Scheelevägen 27, 223 63 Lund. Registration for the AGM starts at 2:00 p.m. CEST.
About Enzymatica AB Enzymatica AB is a Swedish life science company that develops and sells medical devices for infection-related diseases. The products are based on a barrier technology that includes marine enzymes. The company’s first product is ColdZyme® Mouth Spray, Press release. 5 April, 2019. Notice of annual general meeting 2019 in Enzymatica AB (publ) The shareholders in Enzymatica AB (publ), reg.